Clostridium difficile (C. difficile) is a Gram-positive, spore-forming, anaerobic bacillus, which
is widely distributed in the intestinal tract of humans and animals and in the environment. In …

Background Faecal microbiota transplantation (FMT) is effective for recurrent Clostridioides
difficile infection (CDI), but inconsistent effect rates and uncertain evidence levels have …

Ulcerative colitis (UC) is an inflammatory disease that mainly affects the colon and rectum. It
is believed that genetic factors, host immune system disorders, intestinal microbiota …

Background Clostridium difficile infection (CDI) is the commonest nosocomial cause of
diarrhoea. Faecal microbiota transplantation (FMT) is an approved treatment for recurrent or …

Background Fecal microbiota transplantation (FMT) is a microbiota-based therapy that
shows therapeutic potential in recurrent or refractory Clostridium difficile infections and other …

The community of microorganisms within the human gut (or microbiota) is critical to health
and functions with a level of complexity comparable to that of an organ system. Alterations of …

Importance Fecal microbiota transplantation (FMT) has been shown to be effective in
treating relapsing or refractoryClostridium difficileinfection, but practical barriers and safety …

Background: The role of fecal microbiota transplantation (FMT) for Clostridium difficile
infection (CDI) is not well-known. Purpose: To assess the efficacy, comparative …

2014-04-08 Assigned to Seres Health, Inc. reassignment Seres Health, Inc. ASSIGNMENT
OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AFEYAN …

With technological advances in culture‐independent molecular methods, we are uncovering
a new facet of our natural history by accounting for the vast diversity of microbial life which …